IER5 Negatively Regulates Cdc25B Expression in HeLa Cells After Gamma Ray Irradiation

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Radiotherapy is a cornerstone cancer treatment, with cellular sensitivity to radiation determining treatment efficacy.
• The immediate early response 5 (IER5) protein's role in cellular responses to radiation, particularly its impact on key cell cycle regulators, remains largely unexplored.

Purpose of the Study:

• To investigate the effect of IER5 on Cdc25B expression in HeLa cells after gamma irradiation.
• To elucidate the regulatory relationship between IER5 and Cdc25B, and its implications for cell cycle progression.

Main Methods:

• RNA interference (RNAi) was used to knockdown IER5 expression in HeLa cells.
• Quantitative real-time PCR (qRT-PCR) and western blotting were employed to assess mRNA and protein levels.
• Flow cytometry analyzed cell cycle distribution, and Pearson correlation assessed IER5-Cdc25B expression relationships.

Main Results:

• IER5 knockdown significantly altered Cdc25B mRNA and protein expression levels.
• IER5 influenced the G2 phase cell cycle distribution, a process regulated by Cdc25B.
• A negative correlation was observed between IER5 and Cdc25B expression levels post-irradiation.
• IER5 variations affected the expression of putative Cdc25B transcriptional regulators: p53, NF-YB, and p300.

Conclusions:

• IER5 negatively regulates Cdc25B expression in response to gamma irradiation.
• This regulation may involve interactions with transcriptional regulators including p53, NF-YB, and p300.
• Understanding the IER5-Cdc25B axis offers insights into radioresistance mechanisms and potential therapeutic targets in cancer.